Trends in Hospitalization for Female Breast and Gynecological Cancer in China from 2004 to 2020

Overview

Journal Sci Rep

Specialty Science

Date 2024 Nov 7

PMID 39511297

Authors

Xinqiang Zhang

Yuanyuan Li

Guifang Zhang

Changsheng Ma

Min Gao

Affiliations

Soon will be listed here.

Abstract

Breast and gynecological cancers are common cancers with high mortality and have profound effects on the various physical functions of women. This study assessed trends in the number of hospitalizations, in-hospital mortality, length of stay (LOS), and hospital charges for female breast and gynecological cancer from 2004 to 2020. The data for this study come from the China Health Statistics Yearbook. Time trends of categorical variables were assessed with the Cochran-Armitage Test. The linear model was used to test for the trend of continuous variables. The hospitalizations for breast cancer increased from 15,204 to 276,387 (P for trend < 0.001) and gynecological cancer increased from 12,418 to 214,956 (P for trend < 0.001). The in-hospital mortality rate due to breast cancer decreased from 1.70 to 1.07% (P for trend < 0.001). Hospitalizations for both breast and gynecological cancer increased clearly, whether in urban or rural. The gap between urban and rural has narrowed. The average cost per hospitalization for breast cancer significantly increased. However, the average LOS for breast cancer gradually decreased (from 17.0 to 10.7 days, P for trend < 0.001). The average cost per hospitalization for gynecological cancer increased significantly. However, this steady downward trend was observed in the average LOS for gynecological cancer (from 10.34 to 6.69 days, P for trend = 0.003). The increase in hospitalizations and medical expenses for breast and gynecological cancer should encourage healthcare policymakers and healthcare system stakeholders to develop more cost-effective approaches to women's cancer management.

References

Iadeluca L, Mardekian J, Chander P, Hopps M, Makinson G . The burden of selected cancers in the US: health behaviors and health care resource utilization. Cancer Manag Res. 2017; 9:721-730. PMC: 5713681. DOI: 10.2147/CMAR.S143148. View

Yin M, Wang F, Zhang Y, Meng R, Yuan X, Wang Q . Analysis on Incidence and Mortality Trends and Age-Period-Cohort of Breast Cancer in Chinese Women from 1990 to 2019. Int J Environ Res Public Health. 2023; 20(1). PMC: 9820148. DOI: 10.3390/ijerph20010826. View

Yanhua C, Geater A, You J, Li L, Shaoqiang Z, Chongsuvivatwong V . Reproductive variables and risk of breast malignant and benign tumours in Yunnan province, China. Asian Pac J Cancer Prev. 2012; 13(5):2179-84. DOI: 10.7314/apjcp.2012.13.5.2179. View

Youlden D, Cramb S, Dunn N, Muller J, Pyke C, Baade P . The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012; 36(3):237-48. DOI: 10.1016/j.canep.2012.02.007. View

Zhang Q, Liu L, Wang F, Mu K, Yu Z . The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. BMC Public Health. 2012; 12:368. PMC: 3422180. DOI: 10.1186/1471-2458-12-368. View

Crosbie E, Einstein M, Franceschi S, Kitchener H . Human papillomavirus and cervical cancer. Lancet. 2013; 382(9895):889-99. DOI: 10.1016/S0140-6736(13)60022-7. View

Ding R, Xiao Y, Mo M, Zheng Y, Jiang Y, Shao Z . Breast cancer screening and early diagnosis in Chinese women. Cancer Biol Med. 2022; . PMC: 9088185. DOI: 10.20892/j.issn.2095-3941.2021.0676. View

Giaquinto A, Miller K, Tossas K, Winn R, Jemal A, Siegel R . Cancer statistics for African American/Black People 2022. CA Cancer J Clin. 2022; 72(3):202-229. DOI: 10.3322/caac.21718. View

Joko-Fru W, Jedy-Agba E, Korir A, Ogunbiyi O, Dzamalala C, Chokunonga E . The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network. Int J Cancer. 2020; 147(8):2131-2141. DOI: 10.1002/ijc.33014. View

10.

Zheng A, Zhu Y, Wang Y, Liu F, Jin F, Zang S . Assessment of Medical Expenditure for Patients With Breast Cancer in China: Evidence From Current Curative Expenditure by System of Health Accounts 2011. Value Health. 2022; 25(1):77-83. DOI: 10.1016/j.jval.2021.06.015. View

11.

Moore M, Tajima K . Cervical cancer in the asian pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev. 2004; 5(4):349-61. View

12.

Weiderpass E, Persson I, Adami H, Magnusson C, Lindgren A, Baron J . Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control. 2000; 11(2):185-92. DOI: 10.1023/a:1008946825313. View

13.

Lewington S, Li L, Murugasen S, Hong L, Yang L, Guo Y . Temporal trends of main reproductive characteristics in ten urban and rural regions of China: the China Kadoorie biobank study of 300 000 women. Int J Epidemiol. 2014; 43(4):1252-62. PMC: 4121552. DOI: 10.1093/ije/dyu035. View

14.

Sun J, Lyu S, Dai Z . The impacts of socioeconomic status and lifestyle on health status of residents: Evidence from Chinese General Social Survey data. Int J Health Plann Manage. 2019; 34(4):1097-1108. DOI: 10.1002/hpm.2760. View

15.

Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang C . Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years. Eur J Cancer. 2016; 63:1-10. PMC: 4942399. DOI: 10.1016/j.ejca.2016.04.016. View

16.

Fitzmaurice C, Akinyemiju T, Al Lami F, Alam T, Alizadeh-Navaei R, Allen C . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018; 4(11):1553-1568. PMC: 6248091. DOI: 10.1001/jamaoncol.2018.2706. View

17.

Prasad V, De Jesus K, Mailankody S . The high price of anticancer drugs: origins, implications, barriers, solutions. Nat Rev Clin Oncol. 2017; 14(6):381-390. DOI: 10.1038/nrclinonc.2017.31. View

18.

Huang J, Chan P, Lok V, Chen X, Ding H, Jin Y . Global incidence and mortality of breast cancer: a trend analysis. Aging (Albany NY). 2021; 13(4):5748-5803. PMC: 7950292. DOI: 10.18632/aging.202502. View

19.

Ding Y, Chen X, Zhang Q, Liu Q . Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990-2015 breast Cancer mortality data. BMC Public Health. 2020; 20(1):1280. PMC: 7445908. DOI: 10.1186/s12889-020-09375-0. View

20.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View